Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Amsterdam : Elsevier
    Journal of Chromatography B: Biomedical Sciences and Applications 164 (1979), S. 1-8 
    ISSN: 0378-4347
    Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Topics: Chemistry and Pharmacology
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Amsterdam : Elsevier
    Journal of Chromatography B: Biomedical Sciences and Applications 162 (1979), S. 341-350 
    ISSN: 0378-4347
    Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Topics: Chemistry and Pharmacology
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Amsterdam : Elsevier
    Clinica Chimica Acta 114 (1981), S. 249-256 
    ISSN: 0009-8981
    Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Topics: Medicine
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Amsterdam : Elsevier
    Clinica Chimica Acta 60 (1975), S. 379-383 
    ISSN: 0009-8981
    Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Topics: Medicine
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Electronic Resource
    Electronic Resource
    Amsterdam : Elsevier
    Clinica Chimica Acta 42 (1972), S. 315-320 
    ISSN: 0009-8981
    Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Topics: Medicine
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical pharmacology 28 (1985), S. 125-130 
    ISSN: 1432-1041
    Keywords: hypertension ; clonidine ; beta-blocker ; renal failure ; side-effects ; blood pressure decrease ; cardiovascular complications ; atenolol ; propranolol
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary The risk of cardiovascular and fatal complications and the antihypertensive effect of a clonidine-β-blocker combination was studied in 98 patients and was compared with the results for a group of patients treated with other antihypertensive regimens. The profile of complications was similar in the two groups for a total follow-up period of more than 2000 treatment-months. Clonidine in combination either with propranolol or atenolol had a distinct antihypertensive effect. However, clonidine plus atenolol resulted in a more immediate and pronounced fall in blood pressure. It is concluded that the combination of clonidine and a β-blocker is an effective antihypertensive medication, and that patients treated with it are apparently at no greater risk of serious cardiovascular incidents than are those treated with other regimens.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical pharmacology 44 (1993), S. S17 
    ISSN: 1432-1041
    Keywords: Drug protein binding ; uraemia ; high performance liquid chromatography
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary Investigations were undertaken to evaluate which uraemic solutes decrease drug protein binding. This was done by performing HPLC-fractionation of uraemic biological fluids and studying the effect of addition of a lyophilisate of each fraction to normal plasma containing standard quantities of radiolabelled drugs. From a first study, based only on fractionation of uraemic ultrafiltrate with an HPLC-gradient mainly aimed at elution of hydrophilic compounds, hippuric acid appeared to be a major protein binding inhibitor for theophylline and phenytoin. The problem with this approach was that it did not include the compounds with the most substantial protein binding. Therefore, studies were planned to fractionate deproteinized uraemic sera, but first it was necessary to define which deproteinisation methods gave the highest yields of protein bound ligand. Heat denaturation was found to be one of the most effective deproteinisation methods. When a lyophilisate of uraemic serum, deproteinised by this method, was added to normal plasma, a higher capacity to displace theophylline from protein binding sites was found compared to the effect of an identical volume of an ultrafiltrate of the same samples. Fractionation of the deproteinised sample by HPLC revealed a larger number of fractions able to inhibit drug protein binding.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    Electronic Resource
    Electronic Resource
    Springer
    Infection 20 (1992), S. S75 
    ISSN: 1439-0973
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    ISSN: 1439-0973
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Patienten mit Niereninsuffizienz haben eine erhöhte Empfindlichkeit gegenüber Infektionen. Bei Urämie ist die Abtötungskapazität der Phagozyten vermindert. Durch Messung der14CO2-Produktion während der Metabolisierung radioaktiv markierter Glukose durch Phagozyten wurde die bei Phagozytose auftretende “respiratory burst”-Aktivität untersucht. Bei dialysierten und nicht-dialysierten hochgradig niereninsuffizienten Patienten war die Phagozytose auf ca. 50% des Wertes von normalen Probanden vermindert (p〈0.05). Im zweiten Teil der Studie erhielten sechs Dialyse-Patienten Cefodizim (CDZ) 2 g i.v. am Ende der Dialyse (fünf mal während zehn Tagen). Die Phagozytoseaktivität wurde vor Behandlungsbeginn und wiederholt bis zum 29. Tag der Studie bestimmt. CDZ entfaltete einen deutlichen und langdauernden stimulierenden Effekt sowohl auf die Latex- als auch auf die Zymosan-induzierte Phagozytose. Schlußfolgerung: ein normales Therapieschema von CDZ führte zu einer relevanten Stimulation der verminderten Phagozytosetätigkeit bei Dialysepatienten. Der Effekt dauerte über mindestens zwei Wochen nach der letzten Dosis von CDZ an und könnte für urämische Patienten, die eine antibiotische Behandlung benötigen, von Vorteil sein.
    Notes: Summary Patients with renal failure are highly susceptible to infection, in part because uremia decreases the killing capacity of phagocytic leucocytes. Phagocytosis-associated respiratory burst activity was investigated at different stages of renal impairment by measuring the14CO2 production during metabolism of labeled glucose by phagocytic cells. Non-dialyzed end-stage renal failure and haemodialysis patients showed a decrease in phagocytosis to about 50% of normal (p〈0.05). In a second phase of the study, six haemodialysis patients received 2 g cefodizime (CDZ) i.v. after dialysis for ten days (five doses). Phagocytosis was determined at baseline and was followed until day 29. A clear, long-lasting stimulatory effect of CDZ on phagocytosis after both latex and zymosan challenge was found. It is concluded that a usual CDZ dosage regimen stimulates depressed phagocytosis in haemodialysis patients, and that this stimulatory effect persists for at least two weeks after the end of treatment. Uremic patients with infection may benefit from this additional property of CDZ.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    Electronic Resource
    Electronic Resource
    Springer
    Infection 24 (1996), S. 275-291 
    ISSN: 1439-0973
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Antibiotika können direkt mit dem Immunsystem in Wechselwirkung treten. Im Folgenden geben wir eine Übersicht über immunmodulierende Wirkungen von Antibiotika. Medline Datenbasen auf CD-ROM für die Jahre 1987–1994 mit den Stichworten “thesaurus explode antibiotics / all AND (thesaurus explode immune-system/ drug effects ORthesaurus immune-tolerance / drug effects)” wurden befragt. Die immunologischen Studien betrafen Aspekte der Phagozytenfunktionen: Phagozytose und Abtötung sowie Chemotaxis und Aspekte der Lymphozytenfunktion, Lymphozytenproliferation, Zytokinproduktion, Antikörperbildung, Überempfind-lichkeitsreaktion vom verzögerten Typ und natürliche Killerzellaktivität. Um immunmodulierende Eigenschaften von Antibiotika quantifizierbar und vergleichbar zu machen, wurde ein wie folgt definierter “Immunindex” berechnet: Zahl positive Aussagen — Zahl negativer Aussagen/Gesamtaussagen. Positive Wirkungen auf die Phagozyten wurden mit Cefodizim, Imipenem, Cefoxitin, Amphotericin B und Clindamycin gemacht. Bei Erythromycin, Roxithromycin, Cefotaxim, Tetracyklin, Ampicillin und Gentamicin wurden negative Effekte beobachtet. Clindamycin, Cefoxitin und Imipenem induzieren eine Verstärkung der Chemotaxis. Auf die Lymphozyten-proliferation hat Cefodizim den stärksten Stimulationseffekt, Tetrazyklin hat den stärksten negativen Effekt. Die Wirkung auf Zytokinproduktion kann nur für Erythromycin und Amphotericin B beurteilt werden, bei allen anderen Substanzen reichen die Daten hierfür nicht aus. Erythromycin und Amphotericin B führen offensichtlich zu einer Stimulation der Zytokinproduktion. Auf die Antikörperbildung hat Cefodizim die stärkste positive Wirkung, deutlich negative Effekte wurden mit Josamycin, Rifampicin und Tetrazyklin beobachtet. Für die verschiedenen Antibiotika liegen nicht genügend Studien zur Überempfindlichkeitsreaktion vom verzögerten Typ oder zur Natural Killer Cell Aktivität vor. Drei der Antibiotika haben ausgeprägte fördernde Wirkung auf das Immunsystem (Imipenem, Cefodizim, Clindamycin), acht haben ausgeprägt immunsuppressive Wirkung (Erythromycin, Roxithromycin, Cefotaxim, Tetrazyklin, Rifampicin, Gentamicin, Teicoplanin und Ampicillin).
    Notes: Summary Antibiotics can interact directly with the immune system. This is a review of the immunomodulating effects of antibiotics. The Medline database on CD-ROM was searched for the years 1987 to 1994 using the following search string: “thesaurus explode antibiotics / all AND (thesaurus explode immune-system / drug effects ORthesaurus immune-tolerance / drug effects).” Aspects of the immune system studied were aspects of phagocyte functions: phagocytosis and killing, and chemotaxis and aspects of lymphocyte functions: lymphocyte proliferation, cytokine production, antibody production, delayed hypersensitivity and natural killer-cell activity. In order to quantify and to compare immunomodulatory properties of antibiotics we calculated an “immune index,” defined as: number of positive statements — number of negative statements/total number of statements. Concerning phagocytosis, positive effects were observed for cefodizime, imipenem, cefoxitin, amphotericin B and clindamycin and negative effects for erythromycin, roxithromycin, cefotaxime, tetracycline, amplicillin and gentamicin. Clindamycin, cefoxitin and imipenem induce enhancement of chemotaxis, whereas cefotaxime, rifampicin and teicoplanin decrease chemotaxis. Regarding lymphocyte proliferation, cefodizime has the strongest stimulating effect, whereas tetracycline has the strongest negative effect. Except for erythromycin and amphotericin B the number of statements reported is too small to be conclusive for the interpretation of effects on cytokine production. Erythromycin and amphotericin B appear to stimulate cytokine production. As to antibody production, cefodizime has the strongest positive effect, whereas josamycin, rifampicin and tetracycline have marked negative effects. For delayed hypersensitivity and the natural killer-cell activity the number of statements is too small for any single antibiotic to be conclusive. There are three markedly immuno-enhancing antibiotics (imipenem, cefodizime and clindamycin) and eight markedly immuno-depressing antibiotics (erythromycin, roxithromycin, cefotaxime, tetracycline, rifampicin, gentamicin, teicoplanin and ampicillin).
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...